SOUTHWELL DAVID P
Transaction: 08/03/2026
BUY
Change
+150,000
Price
Not reported
Filing
08/05/2026
Type
BUY
Rocket Pharmaceuticals, Inc.
RCKT • Biotechnology
$3.86
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$442.02M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.09Healthy liquidity · 6.38Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:19 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.86
Change0.00%
Shares Out114.51M
Market Cap$442.02M
Enterprise Value$242.31M
52W Range2.53 - 5.45
Beta0.47
P/E-25.62
P/B1.20
P/FCF-2.59
EV/EBITDA-1.37
EV/FCF-1.42
Price$3.86
Change0.00%
Shares Out114.51M
Market Cap$442.02M
Enterprise Value$242.31M
52W Range2.53 - 5.45
Beta0.47
P/E-25.62
P/B1.20
P/FCF-2.59
EV/EBITDA-1.37
EV/FCF-1.42
Earnings Yield-3.90%
FCF Yield-38.55%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.09
Current Ratio6.38
Quick Ratio6.38
Target$23.81
Target Upside516.84%
Target Median$19.50
Target Range2.00 - 69.00
Volume1.68M
Avg Volume2.38M
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
92/100
Why this score▼
Manageable debt level · 0.09Healthy liquidity · 6.38Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 19 analyst votes · 2026-09-05
79/100
Bullish
Bullish
13
Hold
4
Bearish
2
Price Target
2026-08-12
Low
$2.00
Mean
$23.81
Median
$19.50
High
$69.00
Insider Transactions
Recent executive and insider activity
Stevens Christopher James
Transaction: 08/03/2026
BUY
Change
+101,428
Price
$3.41
Filing
08/05/2026
Type
BUY
Stevens Christopher James
Transaction: 08/03/2026
BUY
Change
+73,313
Price
Not reported
Filing
08/05/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| SOUTHWELL DAVID P | BUY | +150,000 | Not reported | 08/03/2026 | 08/05/2026 |
| Stevens Christopher James | BUY | +101,428 | $3.41 | 08/03/2026 | 08/05/2026 |
| Stevens Christopher James | BUY | +73,313 | Not reported | 08/03/2026 | 08/05/2026 |
| Manhede Joseph | OTHER | 0 | Not reported | 07/08/2026 | 07/08/2026 |
| BOESS CARSTEN | BUY | +22,862 | Not reported | 06/18/2026 | 07/06/2026 |
| BOESS CARSTEN | BUY | +64,860 | $3.35 | 06/18/2026 | 07/06/2026 |
| SOUTHWELL DAVID P | BUY | +22,862 | Not reported | 06/18/2026 | 07/06/2026 |
| SOUTHWELL DAVID P | BUY | +64,860 | $3.35 | 06/18/2026 | 07/06/2026 |
| Malik Fady Ibraham | BUY | +22,862 | Not reported | 06/18/2026 | 07/06/2026 |
| Malik Fady Ibraham | BUY | +64,860 | $3.35 | 06/18/2026 | 07/06/2026 |
| Dolsten Mikael | BUY | +64,860 | $3.35 | 06/18/2026 | 07/06/2026 |
| Dolsten Mikael | BUY | +22,862 | Not reported | 06/18/2026 | 07/06/2026 |
| Fong Peter | BUY | +64,860 | $3.35 | 06/18/2026 | 07/06/2026 |
| Fong Peter | BUY | +22,862 | Not reported | 06/18/2026 | 07/06/2026 |
| WONG RODERICK | BUY | +27,832 | Not reported | 06/18/2026 | 07/06/2026 |
| WONG RODERICK | BUY | +78,960 | $3.35 | 06/18/2026 | 07/06/2026 |
| Militello John | SELL | -10,000 | $18.75 | 05/26/2026 | 05/28/2026 |
| Shah Gaurav | SELL | -76,490 | $1.69 | 05/21/2026 | 05/26/2026 |
| Shah Gaurav | SELL | -55,684 | $3.09 | 05/21/2026 | 05/26/2026 |
| Militello John | SELL | -384 | $3.01 | 05/19/2026 | 05/21/2026 |